Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A2GS5D8
Wed, 16.11.2022
Dermapharm Holding SE
Dermapharm Holding SE successfully maintains growth trend as planned
Consolidated revenue up 9.6% to EUR 734.3 million
Adjusted consolidated EBITDA rises 5.1% to EUR 239.4 million
Adjusted consolidated EBITDA margin: 32.6%
"Parallel import business" segment rebounds
Board of Management confirms outlook for 2022 overall
Grünwald, 16 Novem [ … ]
Wed, 16.11.2022
Dermapharm Holding SE
Dermapharm Holding SE successfully maintains growth trend as planned
Consolidated revenue up 9.6% to EUR 734.3 million
Adjusted consolidated EBITDA rises 5.1% to EUR 239.4 million
Adjusted consolidated EBITDA margin: 32.6%
"Parallel import business" segment rebounds
Board of Management confirms outlook for 2022 overall
Grünwald, 16 Novem [ … ]
Wed, 07.09.2022
Dermapharm Holding SE
Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
» Consolidated revenue up year on year by 10.1% to EUR 471.1 million
» Adjusted consolidated EBITDA grew by 8.5% to EUR 148.7 million
» Adjusted consolidated EBITDA margin: 31.6%
» Broadly diversified product portfolio is a key success factor
» Outlo [ … ]
Wed, 07.09.2022
Dermapharm Holding SE
Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
» Consolidated revenue up year on year by 10.1% to EUR 471.1 million
» Adjusted consolidated EBITDA grew by 8.5% to EUR 148.7 million
» Adjusted consolidated EBITDA margin: 31.6%
» Broadly diversified product portfolio is a key success factor
» Outlo [ … ]
Tue, 23.08.2022
Dermapharm Holding SE
Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
Consolidated revenue increased by 10% to EUR 471 million
Adjusted Group EBITDA increases by 9% to EUR 149 million
Broadly diversified product portfolio as an important guarantee for success
Implementation of the C³ Group according to plan
Management Board [ … ]
Tue, 23.08.2022
Dermapharm Holding SE
Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
Consolidated revenue increased by 10% to EUR 471 million
Adjusted Group EBITDA increases by 9% to EUR 149 million
Broadly diversified product portfolio as an important guarantee for success
Implementation of the C³ Group according to plan
Management Board [ … ]
Sat, 30.07.2022
Dermapharm Holding SE
Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
Grünwald, July 30, 2022 – Today, Dermapharm Holding SE ("Dermapharm"), a fast-growing manufacturer of branded pharmaceuticals, acting via its wholly owned subsidiary Dermapharm AG, submitted a binding offer to acquire 100% of the shares in Aph [ … ]
Sat, 30.07.2022
Dermapharm Holding SE
Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
Grünwald, July 30, 2022 – Today, Dermapharm Holding SE ("Dermapharm"), a fast-growing manufacturer of branded pharmaceuticals, acting via its wholly owned subsidiary Dermapharm AG, submitted a binding offer to acquire 100% of the shares in Aph [ … ]
Sat, 30.07.2022
Dermapharm Holding SE
Disclosure of insider information pursuant to Section 17 (1) 1 of Regulation (EU)
No. 596/2014 on market abuse, as amended
(Market Abuse Regulation – MAR)
Dermapharm Holding SE: binding offer to acquire Arkopharma Group
Grünwald, July 30, 2022 – Today, Dermapharm AG, wholly owned subsidiary of Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D [ … ]
Sat, 30.07.2022
Dermapharm Holding SE
Disclosure of insider information pursuant to Section 17 (1) 1 of Regulation (EU)
No. 596/2014 on market abuse, as amended
(Market Abuse Regulation – MAR)
Dermapharm Holding SE: binding offer to acquire Arkopharma Group
Grünwald, July 30, 2022 – Today, Dermapharm AG, wholly owned subsidiary of Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D [ … ]